Abstract:Objective: To observe the selective killing effect of a recombinant Type I Herpes simplex virus (HSV-I)-mediated Gibbon ape leukemia virus membrane fusion glycoprotein (GALV.fus) gene system controlled by UL38 and cytomegalovirus (CMV) promoters on lung adenocarcinoma in vitro. Methods: Lung adenocarcinoma cell line A549, human fetal fibroblast cell line HFL-I GNHu5 and Vero green monkey kidney cells were cultured for study. Recombinant HSV-I plasmids encoding GALV.fus were introduced into Vero cells by liposome to amplify the virus, and then the virus was transfected into A549 and HFL-I GNHu 5 cells. The expression of the recombinant plasmids and antitumor effect in vitro were observed. Recombinant cytomegalovirus (CMV) containing GALV.fus or enhanced green fluorescence protein was used as the control. Total protein was extracted from the transfected A549 and HFL-I GNHu5 cells, and expression of the GALV.fus gene was detected by Western Blot. Results: Recombinant HSV-I virus was packed successfully. The GALV.fus gene system caused A549 cells to form syncytia in vitro and showed increasing cell death with increasing multiplicity of infection. On the other hand, infection with the control virus induced a typical cytopathic effect, characterized by the cells becoming rounder and swelling. HSV Synco-2 was tested for loss of its ability to cause syncytial formation in normal non-dividing human cells by infecting primary human fibroblasts in either a quiescent or a cycling state. Infection with recombinant HSV-I mediated GALV.fus gene system caused syncytial formation in these normal human cells when they were cycling. CMV promoter-me-diated cell fusion was only marginally affected in cells whose cycling was either slowed by serum starvation or completely arrested with lovastatin. UL38 promoter-mediated cell fusion, on the other hand, was absent in cells whose cycling was decreased or arrested. By Western Blot, the expression of GALV.fus gene could be detected in both A549 cells and embryonic fibroblasts transfected by recombinant HSV-I virus. Conclusion: GALV.fus gene system controlled by the UL38 promoter has a powerful selective killing effect against lung adenocarcinoma cells in vitro, and this system may be a promising new candidate for gene therapy for lung cancer.

Evaluation of the Antitumor Activity of Double Fusogenic Virus Against A549 Pulmonary Adenocarcinoma

Antitumor Effect of GALV Membrane Fusion Glycoprotein on Lung Adenocarcinoma in Vivo and in Vitro

Antitumor therapy with GALV membrane fusion glycoprotein mediated by Type I Herpes simplex virus for lung adenocarcinoma in vitro

[The Construction of Recombinant Type I Herpes Simplex Virus Carrying GALV.fus Gene and Its Antitumor Effect in Nude Mice].

Studies on the Therapy of Esophageal Cancer with An Oncolytic Virus Incorporating Fusogenic Membrane Glycoproteins

Gene Therapy of Lung Adenocarcinoma using Herpes Virus Expressing a Fusogenic Membrane Glycoprotein

Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin

Anti-tumor Effects of Gene Therapy with GALV Membrane Fusion Glycoprotein in Lung Adenocarcinoma

Combined Use of Chemotherapeutics and Oncolytic Adenovirus in Treatment of AFP-expressing Hepatocellular Carcinoma

Gene Therapy Targeting Hepatocellular Carcinoma by A Dual-Regulated Oncolytic Adenovirus Harboring the Focal Adhesion Kinase Shrna

Gene Therapy on Chaolangiocarcinoma with Herpes Simplex Virus Thymidine Kinase and Cytosine Deami-Nase Gene in Vivo and in Vitro

In vitro antitumor effect of CD, TK fusion suicide gene induced by adenovirus vector

Combined anti-tumor efficacy of somatostatin fusion protein and vaccinia virus on tumor cells with high expression of somatostatin receptors

HSF1 Overexpression Enhances Oncolytic Effect of Replicative Adenovirus.

Potent Anti-Hepatoma Efficacy of HCCS1 Via Dual Tumor-Targeting Gene-Virotherapy Strategy.

A New Oncolytic Adenoviral Vector Carrying Dual Tumour Suppressor Genes Shows Potent Anti-Tumour Effect

Double-modified oncolytic adenovirus armed with a recombinant interferon-like gene enhanced abscopal effects against malignant glioma.

[Cnhk200-Ha-a Gene-Viral Therapeutic System and Its Antitumor Effect on Lung Cancer].

Antitumor Effects of HSV- Tk and Cytosine Deaminase Double Suicide Gene Mediated by Adenovirus on Cholangiocarcinoma Cells in Vitro

Genetically Programmable Fusion Cellular Vesicles for Cancer Immunotherapy

[Enhanced Transduction Efficiency of Adeno-Associated Virus on Cancer Cells with the Help of Low Dose Adenovirus].